Segmented negative-strand RNA viruses and RIG-I: Divide (your genome) and rule

Current Opinion in Microbiology

Volumn 20, Issue , 2014, Pages 96-102

  Weber, Michaela ^a   Weber, Friedemann ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; NONSTRUCTURAL PROTEIN 1; DEAD BOX PROTEIN; DOUBLE STRANDED RNA; IMMUNOGLOBULIN RECEPTOR; VIRUS RNA;

BASE PAIRING; CYTOPLASM; HANTAVIRUS; INFLUENZA VIRUS; INNATE IMMUNITY; LASSA VIRUS; MESSENGER RNA SYNTHESIS; NEGATIVE STRAND RNA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; RIFT VALLEY FEVER BUNYAVIRUS; RNA VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; ANIMAL; HUMAN; IMMUNE EVASION; IMMUNOLOGY; METABOLISM;

ANIMALS; DEAD-BOX RNA HELICASES; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; RECEPTORS, IMMUNOLOGIC; RNA VIRUSES; RNA, DOUBLE-STRANDED; RNA, VIRAL;

EID: 84902316192     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2014.05.002     Document Type: Review

References (50)

1. Garcia-Sastre A. Induction and evasion of type I interferon responses by influenza viruses. Virus Res 2011, 162:12-18.
2. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
3. Schlee M. Master sensors of pathogenic RNA-RIG-I like receptors. Immunobiology 2013, 218:1322-1335.
4. Ng C.S., Kato H., Fujita T. Recognition of viruses in the cytoplasm by RLRs and other helicases-how conformational changes, mitochondrial dynamics and ubiquitination control innate immune responses. Int Immunol 2012, 24:739-749.
5. Belgnaoui S.M., Paz S., Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 2011, 23:564-572.
6. Goubau D., Deddouche S., Reis E.S.C. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
7. Kohlway A., Luo D., Rawling D.C., Ding S.C., Pyle A.M. Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep 2013, 14:772-779.
8. Kolakofsky D., Kowalinski E., Cusack S. A structure-based model of RIG-I activation. RNA 2012, 18:2118-2127.
9. Kowalinski E., Lunardi T., McCarthy A.A., Louber J., Brunel J., Grigorov B., Gerlier D., Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
10. Schmidt A., Schwerd T., Hamm W., Hellmuth J.C., Cui S., Wenzel M., Hoffmann F.S., Michallet M.C., Besch R., Hopfner K.P., et al. 5'-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009, 106:12067-12072.
11. Malathi K., Saito T., Crochet N., Barton D.J., Gale M., Silverman R.H. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 2010, 16:2108-2119.
12. Saito T., Owen D.M., Jiang F., Marcotrigiano J., Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454:523-527.
13. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., Coch C., Janke M., Mihailovic A., Wardle G., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
14. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006, 80:5059-5064.
15. Elliott R.M., Weber F. Bunyaviruses and the type I interferon system. Viruses 2009, 1:1003-1021.
16. Flick R., Neumann G., Hoffmann E., Neumeier E., Hobom G. Promoter elements in the influenza vRNA terminal structure. RNA 1996, 2:1046-1057.
17. Marq J.B., Hausmann S., Veillard N., Kolakofsky D., Garcin D. Short double-stranded RNAs with an overhanging 5' ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. J Biol Chem 2011, 286:6108-6116.
18. Davis W.G., Bowzard J.B., Sharma S.D., Wiens M.E., Ranjan P., Gangappa S., Stuchlik O., Pohl J., Donis R.O., Katz J.M., et al. The 3' untranslated regions of influenza genomic sequences are 5' PPP-independent ligands for RIG-I. PLoS One 2012, 7:e32661.
19. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
20. Baum A., Sachidanandam R., Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 2010, 107:16303-16308.
21. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt A.M., Veitinger S., Jacob R., Devignot S., Kochs G., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
22. Weber F., Haller O., Kochs G. Conserved vRNA end sequences of Thogoto-orthomyxovirus suggest a new panhandle structure. Arch Virol 1997, 142:1029-1033.
23. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 2008, 3:e2032.
24. Albarino C.G., Bergeron E., Erickson B.R., Khristova M.L., Rollin P.E., Nichol S.T. Efficient reverse genetics generation of infectious Junin viruses differing in glycoprotein processing. J Virol 2009, 83:5606-5614.
25. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
26. Wisskirchen C., Ludersdorfer T.H., Muller D.A., Moritz E., Pavlovic J. The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection. J Virol 2011, 85:8646-8655.
27. Jagger B.W., Wise H.M., Kash J.C., Walters K.A., Wills N.M., Xiao Y.L., Dunfee R.L., Schwartzman L.M., Ozinsky A., Bell G.L., et al. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 2012, 337:199-204.
28. Graef K.M., Vreede F.T., Lau Y.F., McCall A.W., Carr S.M., Subbarao K., Fodor E. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 2010, 84:8433-8445.
29. Iwai A., Shiozaki T., Kawai T., Akira S., Kawaoka Y., Takada A., Kida H., Miyazaki T. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 2010, 285:32064-32074.
30. Rajsbaum R., Albrecht R.A., Wang M.K., Maharaj N.P., Versteeg G.A., Nistal-Villan E., Garcia-Sastre A., Gack M.U. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog 2012, 8:e1003059.
31. Dudek S.E., Wixler L., Nordhoff C., Nordmann A., Anhlan D., Wixler V., Ludwig S. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 2011, 392:1135-1144.
32. Reis A.L., McCauley J.W. The influenza virus protein PB1-F2 interacts with IKKbeta and modulates NF-kappaB signalling. PLoS One 2013, 8:e63852.
33. Varga Z.T., Ramos I., Hai R., Schmolke M., Garcia-Sastre A., Fernandez-Sesma A., Palese P. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog 2011, 7:e1002067.
34. Buettner N., Vogt C., Martinez-Sobrido L., Weber F., Waibler Z., Kochs G. Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor. J Gen Virol 2010, 91:220-227.
35. Vogt C., Preuss E., Mayer D., Weber F., Schwemmle M., Kochs G. The interferon antagonist ML protein of Thogoto virus targets general transcription factor IIB. J Virol 2008, 82:11446-11453.
36. Gori-Savellini G., Valentini M., Cusi M.G. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol 2013, 87:6660-6667.
37. Ikegami T., Narayanan K., Won S., Kamitani W., Peters C.J., Makino S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 2009, 5:e1000287.
38. Habjan M., Pichlmair A., Elliott R.M., Overby A.K., Glatter T., Gstaiger M., Superti-Furga G., Unger H., Weber F. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 2009, 83:4365-4375.
39. Qu B., Qi X., Wu X., Liang M., Li C., Cardona C.J., Xu W., Tang F., Li Z., Wu B., et al. Suppression of the interferon and NF-kappaB responses by severe fever with thrombocytopenia syndrome virus. J Virol 2012, 86:8388-8401.
40. Kainulainen M., Habjan M., Hubel P., Busch L., Lau S., Colinge J., Superti-Furga G., Pichlmair A., Weber F. Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH. J Virol 2014, 88:3464-3473.
41. Verbruggen P., Ruf M., Blakqori G., Overby A.K., Heidemann M., Eick D., Weber F. Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J Biol Chem 2011, 286:3681-3692.
42. Matthys V.S., Cimica V., Dalrymple N.A., Glennon N.B., Bianco C., Mackow E.R. Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation. J Virol 2014, 88:2246-2259.
43. Taylor S.L., Frias-Staheli N., Garcia-Sastre A., Schmaljohn C.S. Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J Virol 2009, 83:1271-1279.
44. Frias-Staheli N., Giannakopoulos N.V., Kikkert M., Taylor S.L., Bridgen A., Paragas J., Richt J.A., Rowland R.R., Schmaljohn C.S., Lenschow D.J., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin-dependent and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2:404-416.
45. Hastie K.M., Kimberlin C.R., Zandonatti M.A., MacRae I.J., Saphire E.O. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A 2011, 108:2396-2401.
46. Qi X., Lan S., Wang W., Schelde L.M., Dong H., Wallat G.D., Ly H., Liang Y., Dong C. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 2010, 468:779-783.
47. Pythoud C., Rodrigo W.W., Pasqual G., Rothenberger S., Martinez-Sobrido L., de la Torre J.C., Kunz S. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J Virol 2012, 86:7728-7738.
48. Rodrigo W.W., Ortiz-Riano E., Pythoud C., Kunz S., de la Torre J.C., Martinez-Sobrido L. Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol 2012, 86:8185-8197.
49. Fan L., Briese T., Lipkin W.I. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 2010, 84:1785-1791.
50. Baeyens K.J., De Bondt H.L., Holbrook S.R. Structure of an RNA double helix including uracil-uracil base pairs in an internal loop. Nat Struct Biol 1995, 2:56-62.